Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maxime Dougados

Showing results (381-390 of 600) with videos related to

Pageof 60
Sort By:
Annals of the Rheumatic Diseases|January 25, 2013
Randomised, controlled trial of avocado-soybean unsaponifiable (Piascledine) effect on structure modification in hip osteoarthritis: the ERADIAS studyEmmanuel Maheu, Christian Cadet, Marc Marty, et al.
The Journal of Rheumatology|December 17, 2017
Prevalence of Comorbidities and Risk Factors for Comorbidities in Patients with Spondyloarthritis in Latin America: A Comparative Study with the General Population and Data from the ASAS-COMOSPA StudyWilson Bautista-Molano, Robert Landewé, Rubén Burgos-Vargas, et al.
Rheumatology (Oxford, England)|July 28, 2018
Which scoring method depicts spinal radiographic damage in early axial spondyloarthritis best? Five-year results from the DESIR cohortSofia Ramiro, Pascal Claudepierre, Alexandre Sepriano, et al.
Rheumatology (Oxford, England)|September 11, 2009
Evaluation of two strategies (initial methotrexate monotherapy vs its combination with adalimumab) in management of early active rheumatoid arthritis: data from the GUEPARD trialMartin Soubrier, Xavier Puéchal, Jean Sibilia, et al.
Arthritis and Rheumatism|June 7, 2013
CCL19, a B cell chemokine, is related to the decrease of blood memory B cells and predicts the clinical response to rituximab in patients with rheumatoid arthritisJérémie Sellam, Stéphanie Rouanet, Houria Hendel-Chavez, et al.
Clinical Rheumatology|February 23, 2018
Phrasing of the patient global assessment in the rheumatoid arthritis ACR/EULAR remission criteria: an analysis of 967 patients from two databases of early and established rheumatoid arthritis patientsLaure Gossec, John Richard Kirwan, Maarten de Wit, et al.
RMD Open|June 30, 2018
Prevalence of degenerative changes and overlap with spondyloarthritis-associated lesions in the spine of patients from the DESIR cohortFreek de Bruin, Marco O Treyvaud, Antoine Feydy, et al.
Rheumatology Advances in Practice|May 29, 2024
Comparing clinical profiles in spondyloarthritis with Crohn's disease or ulcerative colitis: insights from the ASAS-PerSpA studyValeria Rios Rodriguez, Tugba Izci Duran, Murat Torgutalp, et al.
Rheumatology (Oxford, England)|June 15, 2013
Factors associated with radiographic lesions in early axial spondyloarthritis. Results from the DESIR cohortMartin Blachier, Florence Canouï-Poitrine, Maxime Dougados, et al.
Annals of the Rheumatic Diseases|August 16, 2012
Does the site of magnetic resonance imaging abnormalities match the site of recent-onset inflammatory back pain? The DESIR cohortMartin Blachier, Bertrand Coutanceau, Maxime Dougados, et al.
Pageof 60

Showing results (381-390 of 600) with videos related to

Sort By:
Pageof 60
Annals of the Rheumatic Diseases|January 25, 2013
Randomised, controlled trial of avocado-soybean unsaponifiable (Piascledine) effect on structure modification in hip osteoarthritis: the ERADIAS studyEmmanuel Maheu, Christian Cadet, Marc Marty, et al.
The Journal of Rheumatology|December 17, 2017
Prevalence of Comorbidities and Risk Factors for Comorbidities in Patients with Spondyloarthritis in Latin America: A Comparative Study with the General Population and Data from the ASAS-COMOSPA StudyWilson Bautista-Molano, Robert Landewé, Rubén Burgos-Vargas, et al.
Rheumatology (Oxford, England)|July 28, 2018
Which scoring method depicts spinal radiographic damage in early axial spondyloarthritis best? Five-year results from the DESIR cohortSofia Ramiro, Pascal Claudepierre, Alexandre Sepriano, et al.
Rheumatology (Oxford, England)|September 11, 2009
Evaluation of two strategies (initial methotrexate monotherapy vs its combination with adalimumab) in management of early active rheumatoid arthritis: data from the GUEPARD trialMartin Soubrier, Xavier Puéchal, Jean Sibilia, et al.
Arthritis and Rheumatism|June 7, 2013
CCL19, a B cell chemokine, is related to the decrease of blood memory B cells and predicts the clinical response to rituximab in patients with rheumatoid arthritisJérémie Sellam, Stéphanie Rouanet, Houria Hendel-Chavez, et al.
Clinical Rheumatology|February 23, 2018
Phrasing of the patient global assessment in the rheumatoid arthritis ACR/EULAR remission criteria: an analysis of 967 patients from two databases of early and established rheumatoid arthritis patientsLaure Gossec, John Richard Kirwan, Maarten de Wit, et al.
RMD Open|June 30, 2018
Prevalence of degenerative changes and overlap with spondyloarthritis-associated lesions in the spine of patients from the DESIR cohortFreek de Bruin, Marco O Treyvaud, Antoine Feydy, et al.
Rheumatology Advances in Practice|May 29, 2024
Comparing clinical profiles in spondyloarthritis with Crohn's disease or ulcerative colitis: insights from the ASAS-PerSpA studyValeria Rios Rodriguez, Tugba Izci Duran, Murat Torgutalp, et al.
Rheumatology (Oxford, England)|June 15, 2013
Factors associated with radiographic lesions in early axial spondyloarthritis. Results from the DESIR cohortMartin Blachier, Florence Canouï-Poitrine, Maxime Dougados, et al.
Annals of the Rheumatic Diseases|August 16, 2012
Does the site of magnetic resonance imaging abnormalities match the site of recent-onset inflammatory back pain? The DESIR cohortMartin Blachier, Bertrand Coutanceau, Maxime Dougados, et al.
Pageof 60